Growblox Sciences Company Profile (OTCMKTS:GBLX)

About Growblox Sciences

Growblox Sciences logoGrowblox Sciences, Inc. (Growblox) is engaged in developing and utilizing technologies in plant biology, cultivation and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. The Company seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a range of ailments. Growblox intends to conduct its business operations, through its subsidiaries, in approximately three operating units, which include Solutions, Sciences and Product divisions. The Solutions division involves the development and use of its suite of controlled-climate indoor agricultural technology growing and cultivation Suites, including TissueBLOX, GrowBLOX, CureBLOX and ExtractionLAB (collectively, the GrowBLOX Suites). The Science division is engaged in preclinical testing of its biopharmaceutical cannabinoid product prototypes to begin future human clinical trials.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: GBLX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.33
  • 50 Day Moving Average: $0.3151
  • 200 Day Moving Average: $0.2923
  • 52-Week Range: $64,495,000.00 - $0.11
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $21.60M
  • Outstanding Shares: 64,495,000
Additional Links:

Analyst Ratings

Consensus Ratings for Growblox Sciences (OTCMKTS:GBLX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Growblox Sciences (OTCMKTS:GBLX)
No equities research coverage for this company has been tracked by


Earnings History for Growblox Sciences (OTCMKTS:GBLX)
No earnings announcements for this company have been tracked by


Earnings Estimates for Growblox Sciences (OTCMKTS:GBLX)
No earnings estimates for this company have been tracked by


Dividend History for Growblox Sciences (OTCMKTS:GBLX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Growblox Sciences (OTCMKTS:GBLX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2016Lazarus Management Co LlcMajor ShareholderSell785,000$0.31$243,350.00View SEC Filing  
10/8/2014Lazarus Management Co LlcMajor ShareholderBuy77,700$0.69$53,613.00View SEC Filing  
10/2/2014Lazarus Management Co LlcMajor ShareholderBuy39,605$0.85$33,664.25View SEC Filing  
9/29/2014Lazarus Management Co LlcMajor ShareholderBuy64,000$0.90$57,600.00View SEC Filing  
9/17/2014Lazarus Management Co LlcMajor ShareholderBuy47,640$0.76$36,206.40View SEC Filing  
8/27/2014Israel Opportunities F LazarusMajor ShareholderBuy46,625$1.05$48,956.25View SEC Filing  
8/1/2014Israel Opportunities F LazarusMajor ShareholderBuy39,800$1.24$49,352.00View SEC Filing  
7/30/2014Israel Opportunities F LazarusMajor ShareholderBuy87,077$1.24$107,975.48View SEC Filing  
7/2/2014Lazarus Investment Partners LlMajor ShareholderBuy269,632$1.19$320,862.08View SEC Filing  
6/2/2014Lazarus Management Co LlcMajor ShareholderBuy1,000,000$0.50$500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Growblox Sciences (OTCMKTS:GBLX)
DateHeadline logoGrowblox Sciences Inc (OTCMKTS:GBLX) Files An 8-K (OTCMKTS:GBLX) - October 17 at 5:05 PM logoGROWBLOX SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (OTCMKTS:GBLX) - October 15 at 9:58 AM
News IconGrowblox Sciences Announces Patent Application for Treatments of Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease and Dementia (OTCMKTS:GBLX) - October 13 at 8:16 AM logoGrowblox Sciences Announces Patent Application for Treatments of Parkinson's Disease, Alzheimer's Disease, Huntington's Disease and Dementia (OTCMKTS:GBLX) - October 12 at 10:10 AM logoLetter from CEO of Growblox Sciences Regarding Annual Meeting of Shareholders (OTCMKTS:GBLX) - October 11 at 5:24 PM logoGrowblox Sciences, Inc. Acquires Two Additional Medical Cannabis Cultivation And Production Establishment Licenses In The State Of Nevada (OTCMKTS:GBLX) - October 4 at 9:58 AM logoAwareness Continues to Grow for Medical Uses of Cannabis (OTCMKTS:GBLX) - September 29 at 10:10 AM logoGROWBLOX SCIENCES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities (OTCMKTS:GBLX) - September 9 at 4:59 PM
News IconMedical cannabis industry steadily taking off in P.R. (OTCMKTS:GBLX) - August 15 at 11:56 AM logoGROWBLOX SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princi (OTCMKTS:GBLX) - August 11 at 5:24 PM
News IconCANADIAN PHARMACIES SHIPPING TO USA - (OTCMKTS:GBLX) - August 2 at 9:58 AM logoGrowblox Sciences, Inc. with Pacific Leaf Partners LLC, Announces Ownership of Flagship Teco Medical Cannabis Growing Facility (OTCMKTS:GBLX) - July 26 at 8:30 AM logoLetter To Growblox Sciences, Inc. Shareholders From Its CEO (OTCMKTS:GBLX) - July 25 at 8:30 AM logoGrowblox Sciences Forms Growblox Life Sciences, LLC, A Research Organization Focused on Medical Cannabis Scientific Discoveries (OTCMKTS:GBLX) - July 19 at 9:30 AM logoGROWBLOX SCIENCES, INC. Files SEC form 10-K, Annual Report (OTCMKTS:GBLX) - July 14 at 5:31 PM logoGrowblox Sciences, Inc. Announces The Opening Of Its First Medical Marijuana Dispensary: "Showgrow" In Las Vegas, Nevada (OTCMKTS:GBLX) - June 28 at 9:30 AM logoGrowblox Sciences Inc (OTCMKTS:GBLX) Jumps Up On News (OTCMKTS:GBLX) - June 8 at 11:17 PM logoGROWBLOX SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (OTCMKTS:GBLX) - June 7 at 5:17 PM logoGrowBLOX Sciences, Inc. Announces Exclusive Rights To Kyle Kushman's Cannabis Brands, Strains And Genetics In The State Of Nevada (OTCMKTS:GBLX) - June 7 at 9:48 AM logoGrowblox Sciences Inc (OTCMKTS:GBLX) Surges (OTCMKTS:GBLX) - May 31 at 8:39 AM


Growblox Sciences (OTCMKTS:GBLX) Chart for Saturday, October, 22, 2016

Last Updated on 10/22/2016 by Staff